Galen shares dive after relisting

Wednesday 14 October 1998 00:02 BST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

SHARES IN Galen crashed almost 25 per cent yesterday after the Northern Ireland-based pharmaceutical group shelved its pounds 1bn merger with Dutch privately-owned rival Ferring.

Galen, a women's healthcare specialist, said that "in light of current market conditions" the merger talks started in June had been terminated.

The company said that, due to the market turmoil, a share offering planned to finance the deal was "unlikely" to succeed.

The announcement sent Galen shares into freefall. The stock, readmitted to the market yesterday after having been suspended since the start of the talks, closed 100p lower at 337.5p.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

Galen shares dive after relisting

Join our commenting forum

Thank you for registering